SCHEMBL1027990

SCHEMBL1027990

CC(C)(C)N(C(=O)O)c1cccc(CCc2cc(Nc3nc(Cl)ncc3Cl)ccc2N2CCOCC2)c1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 2/20 0.43
BRD4 O60885 2/20 0.43
JAK3 P52333 3/20 0.43
MAPK9 P45984 3/20 0.42
MAPK10 P53779 3/20 0.42
PKMYT1 Q99640 1/20 0.41
EGFR P00533 4/20 0.41
MAPK8 P45983 1/20 0.40
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
TTK P33981 1/20 0.40
BCL6 P41182 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
BTK Q06187 2/20 0.38
NTRK1 P04629 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4336117 0.86 JAK3 (0.51) ALKBRD4JAK3MAPK9MAPK10
SCHEMBL13623215 0.85 JAK3 (0.48) ALKBRD4JAK3MAPK9MAPK10
SCHEMBL4357327 0.83 EGFR (0.39) ALKJAK3EGFRBCL6BTK
SCHEMBL1025607 0.81 STK17B (0.39) EGFRBCL6BTK
SCHEMBL1082585 0.81 MAPK9 (0.46) ALKJAK3MAPK9MAPK10PKMYT1
SCHEMBL1025252 0.79 ALDH1A1 (0.39) MEN1KMT2ASMN1; SMN2
SCHEMBL4352505 0.79 MAPK9 (0.45) ALKBRD4JAK3MAPK9MAPK10
SCHEMBL13669691 0.77 MAPK9 (0.44) ALKBRD4JAK3MAPK9MAPK10
SCHEMBL13622525 0.77 MAPK9 (0.42) ALKBRD4JAK3MAPK9MAPK10
SCHEMBL13623218 0.77 JAK3 (0.51) BRD4JAK3EGFRJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2274288-A2 MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS Incyte Corporation (US) 2011-01-19 EP disclosed